Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Salesforce
CRM
Concentration Risk %
Concentration Risk % at other companies
Gyre Therapeutics, Inc.
GYRE
93.1%
-5.3pp
Heartland Express
HTLD
32%
+6.0pp
Enovix Corporation
ENVX
83%
+36.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Strattec Security
STRT
0.5%
0.0pp
Other financials
Income statement
See full
Revenue
$11.1B
+13.3%
Gross profit
$8.6B
+13.2%
Operating income
$2.3B
+20.9%
Net income
$2.1B
+36.7%
EPS (diluted)
$2.42
+52.2%
Balance sheet
See full
Cash & equivalents
$8.9B
-18.2%
Total debt
$42.5B
+254%
Total equity
$34.2B
-43.6%
Total assets
$106.68B
+8.2%
Cash flow
See full
Operating cash flow
$6.7B
+3.5%
CapEx
$145.0M
-19.0%
Free cash flow
$6.6B
+4.1%
Valuation
See full
Market cap
$123.01B
-50.6%
Enterprise value
$156.62B
-37.4%
P/E
15.3×
-24.8×
P/S
2.9×
-3.6×
Profitability
See full
Gross margin
77.6%
+0.3pp
Operating margin
20.4%
+1.1pp
Net margin
18.7%
+2.7pp
FCF margin
34.2%
+1.5pp
Returns & leverage
See full
Return on equity
16.9%
+6.6pp
Debt / equity
1.2×
+1.0×
Current ratio
0.8×
-0.3×